Diamond Biofund (TPE:6901) Other Long-Term Liabilities: NT$0.03 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6901 Diamond Biofund Inc TPE:6901
24 GF Score
Price NT$16.55
! 2 Warning Signs
View Full Analysis

What is Diamond Biofund Other Long-Term Liabilities?

Diamond Biofund TPE:6901 -0.90% 24 Other Long-Term Liabilities is NT$0.03 Mil as of Jun. 2026. GuruFocus rates TPE:6901 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Diamond Biofund's other long-term liabilities for the quarter that ended in Jun. 2026 was NT$0.03 Mil.

Diamond Biofund's quarterly other long-term liabilities increased from Dec. 2025 (NT$0.02 Mil) to Mar. 2026 (NT$0.03 Mil) but then declined from Mar. 2026 (NT$0.03 Mil) to Jun. 2026 (NT$0.03 Mil).

Diamond Biofund's annual other long-term liabilities stayed the same from Dec. 2023 (NT$0.00 Mil) to Dec. 2024 (NT$0.00 Mil) but then increased from Dec. 2024 (NT$0.00 Mil) to Dec. 2025 (NT$0.02 Mil).

Diamond Biofund Other Long-Term Liabilities Related Terms

Diamond Biofund Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Diamond Biofund's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Other Long-Term Liabilities Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.02

Diamond Biofund Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.02 0.03 0.03
TPE:6901
24GF Score
Diamond Biofund Inc TPE:6901
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biofund Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of NT$0.03 Mil mean?
Diamond Biofund (TPE:6901) has a Other Long-Term Liabilities of NT$0.03 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diamond Biofund and its competitors.
Is Diamond Biofund's Other Long-Term Liabilities too high?
Diamond Biofund's current Other Long-Term Liabilities is NT$0.03 Mil. Overall, Diamond Biofund has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Other Long-Term Liabilities compare to BLK and BX?
Diamond Biofund's Other Long-Term Liabilities of NT$0.03 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for an Asset Management company?
A good Other Long-Term Liabilities depends on the Asset Management industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diamond Biofund and its competitors. Diamond Biofund's current Other Long-Term Liabilities is NT$0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Other Long-Term Liabilities of NT$0.03 Mil. The current Other Long-Term Liabilities is NT$0.03 Mil. Diamond Biofund's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Other Long-Term Liabilities is NT$0.03 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diamond Biofund Business Description

Address Zhongxiao West Road, 34th Floor, No. 66, Section 1, Zhongzheng District, Taipei, TWN, 100
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
24GF Score

Get the complete analysis for TPE:6901

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.55
Price